RNA-seq profiling of 22Rv1 prostate cancer cells exposed to repeated DNA damage for 6 weeks.

RNA-seq profiling of 22Rv1 prostate cancer cell line either untreated, 6 weeks in culture (age matched) or treated daily for 6 weeks with 1 microgram per ml phleomycin to induce DNA damage (n=3 per sample). Overall design: Illumina NovaSeq RNA-seq sequence production of a 100bp single end from RNA extracted from the 3 samples (with 2 biological replicates each) control (untreated 22Rv1 cells), 6 weeks phleomycin/DNA damage and age matched (6 weeks in culture without phleomycin induced DNA damage